X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4358) 4358
Newsletter (341) 341
Publication (255) 255
Book Review (35) 35
Book Chapter (15) 15
Dissertation (13) 13
Newspaper Article (13) 13
Conference Proceeding (9) 9
Government Document (7) 7
Magazine Article (5) 5
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (2710) 2710
flutamide (2582) 2582
humans (2226) 2226
animals (1466) 1466
flutamide - pharmacology (1179) 1179
prostatic neoplasms - drug therapy (1040) 1040
female (1021) 1021
index medicus (908) 908
rats (829) 829
aged (807) 807
flutamide - therapeutic use (807) 807
prostate cancer (803) 803
androgen antagonists - therapeutic use (747) 747
androgen antagonists - pharmacology (718) 718
urology & nephrology (694) 694
middle aged (654) 654
testosterone (597) 597
endocrinology & metabolism (578) 578
prostatic neoplasms - pathology (561) 561
orchiectomy (540) 540
cancer (522) 522
carcinoma (521) 521
oncology (520) 520
flutamide - administration & dosage (492) 492
androgens (468) 468
antineoplastic agents, hormonal - therapeutic use (396) 396
research (377) 377
androgen receptor (363) 363
aged, 80 and over (343) 343
testosterone - pharmacology (341) 341
prostate-specific antigen - blood (330) 330
therapy (321) 321
mice (319) 319
receptors, androgen - metabolism (316) 316
care and treatment (315) 315
androgen antagonists - administration & dosage (312) 312
adult (305) 305
prostatic neoplasms - therapy (295) 295
testosterone - blood (295) 295
flutamide - adverse effects (293) 293
rats, sprague-dawley (285) 285
pharmacology & pharmacy (271) 271
treatment outcome (268) 268
flutamide - analogs & derivatives (258) 258
dihydrotestosterone - pharmacology (251) 251
dose-response relationship, drug (249) 249
analysis (248) 248
time factors (247) 247
prostatic neoplasms - blood (245) 245
castration (242) 242
pregnancy (241) 241
prostatic neoplasms - surgery (236) 236
combined modality therapy (234) 234
antiandrogen (232) 232
toxicology (231) 231
antiandrogens (230) 230
prostatic neoplasms - mortality (227) 227
antineoplastic combined chemotherapy protocols - therapeutic use (225) 225
expression (224) 224
androgen antagonists - adverse effects (221) 221
prostate (216) 216
androgen (215) 215
estrogen (201) 201
androgens - pharmacology (200) 200
anilides - therapeutic use (194) 194
adenocarcinoma - drug therapy (190) 190
drugs (190) 190
universities and colleges (186) 186
neoplasm staging (185) 185
drug therapy, combination (183) 183
trial (183) 183
anilides - pharmacology (182) 182
rat (181) 181
nitriles (179) 179
follow-up studies (178) 178
bicalutamide (177) 177
tosyl compounds (177) 177
estradiol - pharmacology (174) 174
receptors, androgen - genetics (173) 173
prostate - drug effects (170) 170
antineoplastic agents, hormonal - administration & dosage (166) 166
hormones (165) 165
testis - drug effects (165) 165
cells (164) 164
reproductive biology (164) 164
biochemistry & molecular biology (162) 162
organ size - drug effects (162) 162
health aspects (155) 155
prospective studies (152) 152
prostatectomy (150) 150
hirsutism (149) 149
finasteride (148) 148
luteinizing hormone - blood (148) 148
radical prostatectomy (148) 148
rats, wistar (148) 148
prostatic neoplasms - metabolism (145) 145
survival rate (143) 143
cyproterone-acetate (142) 142
gene expression (142) 142
reports (137) 137
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4432) 4432
Spanish (70) 70
Japanese (67) 67
French (48) 48
German (33) 33
Russian (32) 32
Chinese (25) 25
Italian (17) 17
Ukrainian (6) 6
Polish (5) 5
Bulgarian (2) 2
Czech (2) 2
Hungarian (2) 2
Portuguese (2) 2
Danish (1) 1
Dutch (1) 1
Persian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
A current standard treatment for locally advanced prostate cancer is external-beam radiotherapy combined with 3 years of androgen suppression. Adverse events,... 
PHASE-III TRIAL | DEPRIVATION THERAPY | IRRADIATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | EORTC | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | RADIOTHERAPY | RADIATION-THERAPY | ADJUVANT | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Flutamide - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Flutamide - therapeutic use | Prostatic Neoplasms - drug therapy | Drug Administration Schedule | Proportional Hazards Models | Combined Modality Therapy | Prostatic Neoplasms - mortality | Disease-Free Survival | Tosyl Compounds - adverse effects | Heart Diseases - mortality | Tosyl Compounds - therapeutic use | Quality of Life | Radiotherapy, Conformal - adverse effects | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Heart attacks | Medical treatment | Mortality | Radiation therapy | Prostate cancer | Cancer therapies | Quality of life | Index Medicus | Abridged Index Medicus | Androgen Antagonists | Anilides | Life Sciences | Prostatic Neoplasms | Flutamide | Heart Diseases | Radiotherapy, Conformal | Gonadotropin-Releasing Hormone | Nitriles | Tosyl Compounds | Cancer
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 10/2016, Volume 121, p. 737
In this study, we report the synthesis and anti-proliferative effect of a set of eight androst-4-ene-3-one derivatives with different arylcarbamoyl groups at... 
Testosterone | Finasteride | Flutamide | Ketoconazole
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 12/2017, Volume 145, Issue C, pp. 178 - 191
Cytochrome P450 1A2 (CYP1A2) is one of the most abundant and important drug metabolizing enzymes in human liver. However, little is known about the... 
MicroRNA | Toxicity | hsa-miR-132-5p | Drug metabolizing enzymes | CYP1A2 | CANCER PATIENTS | CYTOCHROME-P450 1A2 | FLUTAMIDE | PROLIFERATION | BREAST | HUMAN LIVER-CELLS | METABOLISM | PHARMACOLOGY & PHARMACY | CARCINOMA | DRUG-INTERACTION | Gene Expression Regulation, Enzymologic - drug effects | Lansoprazole - pharmacokinetics | Proton Pump Inhibitors - pharmacology | Humans | MicroRNAs - metabolism | Gene Expression Regulation, Enzymologic - physiology | RNA, Messenger - metabolism | Antineoplastic Agents, Hormonal - pharmacokinetics | Proton Pump Inhibitors - administration & dosage | Computer Simulation | Cytochrome P-450 CYP1A2 - genetics | Lansoprazole - administration & dosage | Cell Line | Antineoplastic Agents, Hormonal - pharmacology | RNA Processing, Post-Transcriptional - drug effects | Antineoplastic Agents, Hormonal - administration & dosage | RNA, Messenger - genetics | Cell Proliferation - physiology | Cytochrome P-450 CYP1A2 - metabolism | Flutamide - pharmacology | Proton Pump Inhibitors - pharmacokinetics | Lansoprazole - pharmacology | Cell Proliferation - drug effects | MicroRNAs - genetics | Flutamide - administration & dosage | Flutamide - pharmacokinetics | Liver cancer | Epigenetic inheritance | Liver | Genomics | Cytochrome P-450 | Genetic research | Genetic transcription | Health savings accounts | Index Medicus
Journal Article
Journal of Investigative Surgery, ISSN 0894-1939, 2018, pp. 1 - 8
The aim of this study was to identify a theoretical support for the prevention of urethral fistula following hypospadias repair, by comparing the preputial... 
hypospadias | flutamide | prepuce | fistula
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2018, Volume 36, Issue 11, pp. 1080 - 1087
PurposeDocetaxel added to androgen-deprivation therapy (ADT) significantly increases the longevity of some patients with metastatic hormone-sensitive prostate... 
ANDROGEN-DEPRIVATION THERAPY | ONCOLOGY | MEN | FLUTAMIDE | DNA-REPAIR | CASTRATION | DOCETAXEL | ORIGINAL REPORTS
Journal Article
Journal Article
The Journal of Dermatology, ISSN 0385-2407, 02/2019, Volume 46, Issue 2, pp. e52 - e54
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1504 - 1515
Journal Article
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, ISSN 1386-1425, 10/2014, Volume 131, p. 249
Display Omitted 
Flutamide | Comparative analysis
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 06/2016, Volume 22, Issue 22, pp. 3303 - 3304
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2017, Volume 98, Issue 2, pp. 296 - 303
Journal Article